MeSH 搜索器

Risk Evaluation and Mitigation

Strategies required by the US Food and Drug Administration (FDA) Amendments Act of 2007 when a question exists as to whether the benefits of a drug outweigh its risks. These constitute a safety plan with several potential components, including a medication guide, a communication plan, elements to ensure safe use and an implementation system to help guide the prescribers, pharmacists and patients.
推出的年份: 2018
副标题
树号: N04.452.871.758, N06.850.505.715.750
MeSH 单一 ID: D000073938
进入的组:
  • Elements to Assure Safe Use
  • ETASU
早前的内容:
  • Risk Assessment (2009-2017)
  • Risk Management (2008-2017)

留言 (0)

沒有登入
gif